PRESS RELEASE

from Thalassa Holdings Ltd (isin : VGG878801114)

Thalassa Holdings Ltd: 2024 Interim Results

Thalassa Holdings Ltd (THAL)
Thalassa Holdings Ltd: 2024 Interim Results

27-Sep-2024 / 07:00 GMT/BST


 

 

Thalassa Holdings Ltd

 

 

 

Thalassa Holdings Ltd

(Reuters: THAL.L, Bloomberg: THAL:LN)

("Thalassa" or the "Company")

Interim Results for the period ended 30 June 2024

 

The Company is pleased to announce its results for the six months ended 30 June 2024. The unaudited interim results have been submitted to the FCA and will shortly be available on the Company’s website: www.thalassaholdingsltd.com

 

Highlights for the 6 months ended 30 June 2024

GROUP RESULTS 1H 2024 versus 1H 2023, unless otherwise stated (Unaudited)

 

Profit /(loss) after tax for the year

£0.24m vs (£0.53)m

Group Earnings Per Share (basic and diluted)*1

£0.03 vs (£0.07)

Book value per share*2

£1.19 vs £1.20

Investment Holdings *3

£8.8m vs £7.7m

Cash

£1.4m vs £0.6m

 

 

 

 

*1 based on weighted average number of shares in issue of 7,945,838 (2023: 7,945,838)

 

*2 based on actual number of shares in issue as at 30 June 2024 of 7,945,838 (2023: 7,945,838)

 

*3 including all holdings excl. cash

 

 

Chairman’s Statement

2024 Observations

  • The US Federal Reserve cut the Fed Funds Rate by 0.5% to 5.0% from 5.5%
  • First US Rate cut for 4 years
  • Dow Jones and S&P hit new highs
  • NASDAQ leads 2024 performance +20% YTD.
  • Through 7 September 2023, the tech-heavy NASDAQ Composite (CCMP) has risen ~20%; Notable Mega Caps AAPL +18.87%, NVDA +138.02%, TSLA -1.84% GOOGL +16.07%, META +57.96% EBAY +44.93%, MSFT +16.66%.
  • NVDA’s performance alone accounts for 20% of S&P 500 ‘s YTD performance of +19.8%.
  • Buffett Index at an all-time high; Total US Market Value recently @ 200% of US GDP. Next stop infinity!
  • On Aug 30, 2021, the Buffett Index stood at 199.5%,  shortly before falling over 30%.
  • A reversion to the Mean from current levels would indicate a possible (porbable) decline of between 30 to 50% - assuming no overshoot!
  • US Household Debt at the end of Q2 2024 stood at a record $17.8 trillion. (Source, New York Fed Aug 6, 2024); +505bn from Q2 2023.
  • Over the last year, approximately 9.1% of US credit card balances and 8.0% of US auto loan balances transitioned into delinquency. (Source, as above).
  • US Federal Debt $35.4 trillion, 123.44% of GDP.

 

Holdings -

Restitution  -

  • As at the time of writing I have so far covered £2,086,00 for the losses incurred by the Company due to the collapse of Tappit, due wholly, in my opinion, to the incompetence of the Company’s Board. I will continue to contribute funds up to a total of £3m.

 

NWT - https://newmarksecurity.com/

  • Newmark Security recently published Full Year 2024 (Yr end 30 April) results, which confirmed our view on recovery with Revenues up +10% and EBITDA up +50%. NWT shares have also performed well since the beginning of the year and have increased 26.67% YTD.

 

ALNA - https://www.alina-holdings.com/

  • ALNA posted improved results for H1 2024 which can be found on the Company’s website, as above.

 

AMOI - https://anemoi-international.com/

  • Please refer to Anemoi website

 

SUN - https://www.sigroupplc.com/

  • Surgical Innovations Group PLC (SUN LN)

is a leading UK-based designer, manufacturer, and exporter of innovative high quality medical products primarily for use in laparoscopic and robotic minimally invasive surgery.

THAL has recently taken a 15.8% stake in SUN. In the early 90’s I was the first Wall Street banker to visit Conmed (CNMD US), at the time it had a market cap. of ~$30m, today its mkt cap. is $2.3bn. The Medical Device Market (including Laparoscopy) is dominated by Medtronic plc $31.6bn revenues, Abbott Labs $31.3bn revenues, Dasher Corp $29.6bn, John & Johnson $27.4bn, as well as Siemens, Fresenius Medline, Becton Dickinson, GE Healthcare, Stryker, Philips NV, Cardinal Health, Baxter Intl., Boston Scientific all with annual revenues in excess of $10bn.

SUN’s H1 2024 results are due 30 September, and whilst our expectations are muted, we believe that the Company has exceptional leadership in place for such a small company and can and should, in due course, return to profitability.

 

ALSAF  -   https://safegrp.com/

  • Safe Group is a leader of ready-to-use solutions for the treatment of Spinal Diseases.

 

THAL has recently acquired a 10% stake in SAFE.

 

Conclusion

Warren Buffett is quoted as saying, “Be fearful when others are greedy, and greedy when others are fearful. Now is not the time to be greedy but fearful. Berkshire Hathaway has a record amount of cash ~$300bn and continues to sell holdings. The US market is experiencing peak earnings and multiples whilst Federal and Consumer debt are both at all-time highs.

Duncan Soukup

Chairman

Thalassa Holdings Ltd

26 September 2024

 

 

Responsibility Statement

 

 

We confirm that to the best of our knowledge:

 

  1. the condensed set of financial statements has been prepared in accordance with IAS 34 ‘Interim Financial Reporting’ and gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation as a whole as required by DTR 4.2.4 R;

 

  1. the interim management report includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

 

  1. the interim management report includes a fair review of the information required by DTR 4.2.8R (disclosure of related parties’ transactions and changes therein).

 

 

Cautionary statement

This Interim Management Report (IMR) has been prepared solely to provide additional information to shareholders to assess the Company’s strategies and the potential for those strategies to succeed. The IMR should not be relied on by any other party or for any other purpose.

 

 

 Duncan Soukup

Chairman

Thalassa Holdings Ltd

26 September 2024

  

Total income from operations for the period to 30 June 2024 was £0.3m (1H23: £0.2m). Income benefited from a £0.2m unrealised gain on Thalassa’s holding in NWT.

Cost of Sales was £5k (1H23: £15k) comprising development costs (net of capitalised costs) at ARL and direct financial holdings expenses, resulting in a Gross Profit of £0.3m (1H23: gross profit £0.2m).

Administration expenses were negative £0.1m, i.e. a slight income (1H23: £0.4m expense). This was positively impacted by the decision of the Chairman to waive all of his consultancy fees carried forward from 2022 and 2023. We should like to point out that, as in past periods, Mr Soukup’s 2024 fees have been accrued, but not yet paid. Depreciation costs were £0.01m (1H23: £0.16m). This reduction was due to the surrender of the Swiss office lease by the Company’s subsidiary Alfalfa.

Operating Profit improved to £0.3m (1H23 Loss: £0.4m).

Other income benefited from a £17k net gain on book value on the surrender of the afore mentioned lease. Until surrender, some of this property had been sublet, which covered total lease expenditure.

Profit before tax was £0.2m (1H23 loss: £0.5m).

Net assets at 30 June 2024 amounted to £9.5m (1H23: £9.6m).

Net cash (being cash balances less any financial borrowings) was £1.4m as at 30 June 2024 (1H23: £0.6m).

Current and Non-current lease liabilities became nil on the surrender of the Villa Kramerstein lease.

The reduction in other receivables and other payables was driven by the formal offsetting of most of a receivables balance from an entire payables balance to a single counterparty, ID4 AG / Apeiron AG. The payable was from Alfalfa in relation to an assets purchase from id4 AG prior to the acquisition by the Company; and the receivable is in relation to a balance owed to the Company from the former Apeiron AG.

Net cash outflow from operating activities amounted to £0.15m compared to  £0.10m in 1H23.

Net cash outflow from investing activities amounted to £0.02m, compared to 1H23 inflow of £0.39m.

Net cash inflow from financing activities amounted to £1.45m (1H23: outflow £0.14m). This was driven by the Tappit restitution agreement. The Chairman contributed £1.5m in the 6 month period to 30 June 2024. A further £0.6m was contributed by the Chairman in August 2024.

 

Interim Condensed Consolidated Statement of Income

For the six months ended 30 June 2024

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 Jun 24

30 Jun 23

31 Dec 23

 

Unaudited

Unaudited

Audited

Note

GBP

GBP

GBP

Income

 

102,599

118,673

252,129

Net gains/(losses) on investments at fair value

 

198,600

118,426

282,809

Investment dividend income

 

4,153

770

770

Currency gains/(losses)

 

440

-

48

Total Income

 

305,792

237,869

535,756

Financial holdings expenses

 

(4,987)

(7,958)

(15,199)

Other cost of sales

 

(312)

(7,096)

(12,926)

Total Cost of sales

 

(5,299)

(15,054)

(28,125)

Gross Profit

 

300,493

222,815

507,631

Administrative expenses excluding exceptional costs

 

102,674

(429,067)

(900,853)

Operating profit/(loss) before depreciation

 

403,167

(206,252)

(393,222)

Depreciation and Amortisation

4&5

(92,676)

(164,488)

(256,425)

Operating profit/(loss)

 

310,491

(370,740)

(649,647)

See all Thalassa Holdings Ltd news